A L Stoll

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial
    A L Stoll
    Brigham and Women s Hospital, Department of Psychiatry, Harvard Medical School, Boston, Mass, USA
    Arch Gen Psychiatry 56:407-12. 1999
  2. pmc Gait unsteadiness and fall risk in two affective disorders: a preliminary study
    Jeffrey M Hausdorff
    Division on Aging, Harvard Medical School, Boston, MA, USA
    BMC Psychiatry 4:39. 2004
  3. ncbi request reprint Mood stabilizer combinations: a review of safety and efficacy
    M P Freeman
    Psychopharmacology Unit, Division of Psychiatry, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Psychiatry 155:12-21. 1998
  4. ncbi request reprint Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex
    C M Moore
    Brain Imaging Center, McLean Hospital, Belmont, MA, USA
    Bipolar Disord 2:207-16. 2000
  5. ncbi request reprint Psychiatric agriculture: systemic nutritional modification and mental health in the developing world
    Douglas S London
    Psychopharmacological Research Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA
    Med Hypotheses 66:1234-9. 2006
  6. ncbi request reprint Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats
    William A Carlezon
    Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
    Biol Psychiatry 57:343-50. 2005
  7. doi request reprint Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients
    J Eric Jensen
    Brain Imaging Center, McLean Hospital, Belmont, Massachusetts 02478 9106, USA
    Exp Clin Psychopharmacol 16:199-206. 2008
  8. ncbi request reprint Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator
    Michael Rohan
    Brain Imaging Center, McLean Hospital, Belmont, MA 02478, USA
    Am J Psychiatry 161:93-8. 2004
  9. ncbi request reprint S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects
    Marisa M Silveri
    Department of Psychiatry, Harvard Medical School, Boston, MA, USA
    Biol Psychiatry 54:833-9. 2003
  10. ncbi request reprint How blind is double-blind? A study of fish oil versus placebo
    Karen E Damico
    Psychopharmacology Research Laboratory, Center for the Development of Novel and Natural Treatments for Mood Disorders, McLean Hospital, Belmont, MA 02478, USA
    Prostaglandins Leukot Essent Fatty Acids 66:393-5. 2002

Detail Information

Publications16

  1. ncbi request reprint Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial
    A L Stoll
    Brigham and Women s Hospital, Department of Psychiatry, Harvard Medical School, Boston, Mass, USA
    Arch Gen Psychiatry 56:407-12. 1999
    ..The present study was performed to examine whether omega3 fatty acids also exhibit mood-stabilizing properties in bipolar disorder...
  2. pmc Gait unsteadiness and fall risk in two affective disorders: a preliminary study
    Jeffrey M Hausdorff
    Division on Aging, Harvard Medical School, Boston, MA, USA
    BMC Psychiatry 4:39. 2004
    ....
  3. ncbi request reprint Mood stabilizer combinations: a review of safety and efficacy
    M P Freeman
    Psychopharmacology Unit, Division of Psychiatry, Brigham and Women s Hospital, Boston, MA 02115, USA
    Am J Psychiatry 155:12-21. 1998
    ..Polypharmacy is common in the treatment of refractory bipolar disorder. The purpose of this article is to review the safety and efficacy of mood stabilizers in combinations...
  4. ncbi request reprint Choline, myo-inositol and mood in bipolar disorder: a proton magnetic resonance spectroscopic imaging study of the anterior cingulate cortex
    C M Moore
    Brain Imaging Center, McLean Hospital, Belmont, MA, USA
    Bipolar Disord 2:207-16. 2000
    ..We wished to determine the relationship between anterior cingulate cortex choline and myo-inositol levels, assessed using proton magnetic resonance spectroscopic imaging (MRSI), and mood state in subjects with bipolar disorder...
  5. ncbi request reprint Psychiatric agriculture: systemic nutritional modification and mental health in the developing world
    Douglas S London
    Psychopharmacological Research Laboratory, McLean Hospital, Harvard Medical School, Belmont, MA, USA
    Med Hypotheses 66:1234-9. 2006
    ....
  6. ncbi request reprint Antidepressant-like effects of uridine and omega-3 fatty acids are potentiated by combined treatment in rats
    William A Carlezon
    Department of Psychiatry, Harvard Medical School, McLean Hospital, Belmont, Massachusetts, USA
    Biol Psychiatry 57:343-50. 2005
    ..We also examined the effects of omega-3 fatty acids (OMG), which increase membrane fluidity and reportedly have antidepressant effects in humans, alone and in combination with uridine...
  7. doi request reprint Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients
    J Eric Jensen
    Brain Imaging Center, McLean Hospital, Belmont, Massachusetts 02478 9106, USA
    Exp Clin Psychopharmacol 16:199-206. 2008
    ..These results suggest that TAU treatment may decrease symptoms of depression and improve mitochondrial functioning...
  8. ncbi request reprint Low-field magnetic stimulation in bipolar depression using an MRI-based stimulator
    Michael Rohan
    Brain Imaging Center, McLean Hospital, Belmont, MA 02478, USA
    Am J Psychiatry 161:93-8. 2004
    ..This study evaluated possible mood improvement associated with this procedure...
  9. ncbi request reprint S-adenosyl-L-methionine: effects on brain bioenergetic status and transverse relaxation time in healthy subjects
    Marisa M Silveri
    Department of Psychiatry, Harvard Medical School, Boston, MA, USA
    Biol Psychiatry 54:833-9. 2003
    ....
  10. ncbi request reprint How blind is double-blind? A study of fish oil versus placebo
    Karen E Damico
    Psychopharmacology Research Laboratory, Center for the Development of Novel and Natural Treatments for Mood Disorders, McLean Hospital, Belmont, MA 02478, USA
    Prostaglandins Leukot Essent Fatty Acids 66:393-5. 2002
    ..The results suggest that altering subjects' expectations could further improve the validity of the double-blind...
  11. ncbi request reprint Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry
    Marlene P Freeman
    Women s Mental Health Program, Department of Psychiatry, University of Arizona College of Medicine, Tucson 85724 5002, USA
    J Clin Psychiatry 67:1954-67. 2006
    ..To determine if the available data support the use of omega-3 essential fatty acids (EFA) for clinical use in the prevention and/or treatment of psychiatric disorders...
  12. ncbi request reprint Brain metabolic alterations in medication-free patients with bipolar disorder
    Stephen R Dager
    Department of Radiology, University of Washington, Seattle 98105, USA
    Arch Gen Psychiatry 61:450-8. 2004
    ..Bipolar disorder (BD) has substantial morbidity and incompletely understood neurobiological underpinnings...
  13. ncbi request reprint Omega-3 fatty acid treatment and T(2) whole brain relaxation times in bipolar disorder
    Fuyuki Hirashima
    Brain Imaging Center, McLean Hospital, Belmont, MA, USA
    Am J Psychiatry 161:1922-4. 2004
    ..The authors hypothesized that changes in brain membrane composition resulting from omega-3 fatty acid administration in patients with bipolar disorder would result in greater membrane fluidity, as detected by reductions in T(2) values...
  14. ncbi request reprint Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder
    Seth D Friedman
    Department of Radiology, University of Washington, Seattle, Washington, USA
    Biol Psychiatry 56:340-8. 2004
    ..This study examined whether lithium (Li) and valproic acid (VPA) treatment modulated these chemicals...
  15. ncbi request reprint Frontal lobe gray matter density decreases in bipolar I disorder
    In Kyoon Lyoo
    Brain Imaging Center, McLean Hospital, Belmont, Massachusetts 02478, USA
    Biol Psychiatry 55:648-51. 2004
    ..This study was conducted to explore differences in gray and white matter density between bipolar and healthy comparison groups using voxel-based morphometry (VBM)...
  16. ncbi request reprint Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans
    Jessica L Goren
    Psychopharmacology Research Laboratory, Program for the Development of Natural and Novel Treatments for Bipolar Disorder, McLean Hospital, Belmont, Massachusetts
    Pharmacotherapy 24:1501-7. 2004
    ..Serum homocysteine levels were also measured since alterations in these levels have been theorized in association with SAMe...